Reduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung Cancer
Open Access
- 15 February 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (4), 1207-1212
- https://doi.org/10.1158/0008-5472.can-04-3461
Abstract
Chromosomal deletions are often observed in lung cancers suggesting that inactivation of tumor suppressor genes plays an important role in the development of this neoplasm. The region around chromosome 8p22 is a frequent and early target of these deletions and has therefore been investigated for the presence of candidate genes. The FEZ1/LZTS1 gene, located at 8p22, is inactivated in many cancers with 8p deletions, including prostate, esophageal, gastric, bladder, and breast cancer and the Fez1 protein has been shown to suppress growth of cancer cells and to regulate mitosis. To elucidate the role of FEZ1 in lung cancer, we have analyzed its expression by immunohistochemistry in 103 primary lung cancer specimens including 98 non–small cell lung cancers (57 adenocarcinomas, 32 squamous cell carcinomas, 7 large cell carcinomas, and 2 others) and five small cell carcinomas. Absence of Fez1 protein expression was observed in 27 cases (26%) and additional 43 cases (42%) showed strong reduction in immunoreactivity. There was a positive association between loss of FEZ1 expression and tumor grading (P = 0.0345) and a tendency toward a reduction in the mortality rate in subjects with strong FEZ1 expression. Overall, these data indicate an important role for FEZ1 in lung cancer and suggest the possibility that it may serve as a novel prognostic indicator.Keywords
This publication has 23 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancerInternational Journal of Cancer, 2003
- p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective StudyJNCI Journal of the National Cancer Institute, 2003
- FEZ1/LZTS1 Is Down-Regulated in High-Grade Bladder Cancer, and Its Restoration Suppresses Tumorigenicity in Transitional Cell Carcinoma CellsThe American Journal of Pathology, 2002
- Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22Oncogene, 2001
- The Hallmarks of CancerCell, 2000
- PRLTS Gene Alterations in Human Prostate CancerJapanese Journal of Cancer Research, 1997
- Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumoursCytogenetic and Genome Research, 1997
- Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transferGenes, Chromosomes and Cancer, 1996
- LOSS OF CONSTITUTIONAL HETEROZYGOSITY IN HUMAN CANCERAnnual Review of Genetics, 1991